Latest round of Research Forward supports cross-campus collaborations and diversity
Sixteen projects have been selected for funding in the second round of Research Forward, a program to stimulate innovative and groundbreaking research at UW–Madison that is collaborative, multidisciplinary and potentially transformative.
The winning projects were chosen from 96 proposals submitted by applicants across campus. They range from establishing a Microbial Natural Products Discovery Hub, to probing the origins of the universe, to examining the negative effects of poverty on adolescent academic success, to developing a new type of anti-tumor vaccine that can be used to treat cancer.
Congratulations to three CMB Trainers who had projects selected:
- Development of 3D-Printed Piezoelectric Stents with Self-Powered Anti-Restenosis Properties, Bo Liu, professor of surgery. This project seeks to propose a stent that has self-generated electrical potential that can resist cell buildup without the need for drugs.
- Programmable, Pro-Regenerative Immune Cell Therapies for Neurodegeneration and Brain Injury, Krishanu Saha, associate professor of biomedical engineering. This project develops a new concept to treat brain disorders, injuries and aging via cell therapy — with potential applications in the treatment of Alzheimer’s disease and Parkinson’s disease.
- Towards a Mechanistic Understanding of How Bile Acids Modulate Gut Microbiome Composition and Function, Daniel Amador-Noguez, associate professor of bacteriology. The overarching goal of this project is to establish causal relationships between the bile acid pool and the gut microbiome composition.
The full story is available here.